JAZZ PHARMACEUTICALS PLC (JAZZ)

IE00B4Q5ZN47 - Common Stock

132.26  -0.51 (-0.38%)

After market: 132.26 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.364B
9.33%
3.094B
30.91%
3.659B
18.27%
3.911B
6.88%
EBITDA
YoY % growth
792.5M
-12.19%
951.8M
20.10%
738.4M
-22.42%
1.758B
138.08%
N/AN/AN/A
EBIT
YoY % growth
514.2M
-3.42%
399.3M
-22.35%
108.9M
-72.73%
1.709B
1,469.33%
Operating Margin
21.75%12.90%2.98%43.70%
EPS
YoY % growth
12.47
-23.21%
16.23
30.15%
13.13
-19.10%
18.77
42.97%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
5.26
7,615.07%
Revenue
Q2Q % growth
1.027B
5.65%
EBITDA
Q2Q % growth
460.16M
EBIT
Q2Q % growth
448.87M
270.41%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
4.84
-6.38%
5.03-0.19-3.79%
Q2 2023
Q2Q % growth
4.51
4.88%
4.52-0.01-0.23%
Q1 2023
Q2Q % growth
3.95
5.90%
4.32-0.37-8.66%
Q4 2022
Q2Q % growth
-0.07
-101.66%
0.33-0.40-121.41%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
972.1M
3.34%
985.21M-13.11M-1.33%
Q2 2023
Q2Q % growth
957.3M
2.62%
961.72M-4.42M-0.46%
Q1 2023
Q2Q % growth
892.8M
9.72%
913.34M-20.54M-2.25%
Q4 2022
Q2Q % growth
972.1M
8.41%
995.11M-23.01M-2.31%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.16% 0.28% 0% -1.39%
Revenue0.49% -0.19% 0% 0.03%